Safety and efficacy of mycophenolate in COVID-19.
作者信息
Zeng Guangting, Liu Xiangting, Wang Xia, Li Hui
机构信息
Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China.
Reproductive Medicine Center, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China.
出版信息
Lancet Reg Health Southeast Asia. 2023 Nov 8;22:100321. doi: 10.1016/j.lansea.2023.100321. eCollection 2024 Mar.
Abstract
摘要
相似文献
1
Safety and efficacy of mycophenolate in COVID-19.霉酚酸酯在新型冠状病毒肺炎中的安全性和有效性
Lancet Reg Health Southeast Asia. 2023 Nov 8;22:100321. doi: 10.1016/j.lansea.2023.100321. eCollection 2024 Mar.
2
Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western India.霉酚酸酯在新型冠状病毒肺炎中的安全性和有效性：印度西部的一项非随机前瞻性研究
Lancet Reg Health Southeast Asia. 2023 Apr;11:100154. doi: 10.1016/j.lansea.2023.100154. Epub 2023 Jan 25.
3
Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.霉酚酸酯与环磷酰胺治疗狼疮性肾炎诱导缓解的疗效和安全性：一项随机对照试验的荟萃分析。
Drugs. 2012 Jul 30;72(11):1521-33. doi: 10.2165/11635030-000000000-00000.
4
Enteric-coated mycophenolate sodium - current and future use in transplant patients.肠溶剂型麦考酚钠——在移植患者中的现有和未来应用。
Expert Rev Clin Immunol. 2005 Jul;1(2):203-11. doi: 10.1586/1744666X.1.2.203.
5
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial.尼达尼布在接受霉酚酸治疗的系统性硬化症相关间质性肺疾病患者中的疗效和安全性：SENSCIS试验的亚组分析
Lancet Respir Med. 2021 Jan;9(1):96-106. doi: 10.1016/S2213-2600(20)30330-1.
6
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.在未对两到三剂 mRNA 疫苗（RECOVAC）产生应答的肾移植受者中提高 COVID-19 疫苗免疫原性的替代策略：一项随机临床试验。
Lancet Infect Dis. 2023 Mar;23(3):307-319. doi: 10.1016/S1473-3099(22)00650-8. Epub 2022 Oct 27.
7
Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.长期霉酚酸钠治疗寻常型天疱疮的疗效和安全性。
J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1432-4. doi: 10.1111/j.1468-3083.2009.03226.x. Epub 2009 Mar 17.
8
Systemic safety analysis of mycophenolate in Graves' orbitopathy.麦考酚酯在格雷夫斯眼病中的系统安全性分析。
J Endocrinol Invest. 2020 Jun;43(6):767-777. doi: 10.1007/s40618-019-01161-z. Epub 2019 Dec 13.
9
Efficacy and Safety of Switching to Azathioprine for Mycophenolate-Induced Diarrhea in Renal Transplant Recipients.转换用阿扎胞苷治疗霉酚酸酯诱导的腹泻在肾移植受者中的疗效和安全性。
Transplant Proc. 2021 Jul-Aug;53(6):1951-1956. doi: 10.1016/j.transproceed.2021.06.020. Epub 2021 Jul 15.
10
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.在无关供体非清髓性造血干细胞移植后的患者中，在基于标准环孢素加霉酚酸酯预防移植物抗宿主病的基础上加用西罗莫司：一项多中心、随机、3期试验。
Lancet Haematol. 2019 Aug;6(8):e409-e418. doi: 10.1016/S2352-3026(19)30088-2. Epub 2019 Jun 24.
本文引用的文献
1
Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western India.霉酚酸酯在新型冠状病毒肺炎中的安全性和有效性：印度西部的一项非随机前瞻性研究
Lancet Reg Health Southeast Asia. 2023 Apr;11:100154. doi: 10.1016/j.lansea.2023.100154. Epub 2023 Jan 25.
Zotero 插件